FDA conditionally approves QYLEKI as brand name for Quoin drug

Go back to FDA conditionally approves QYLEKI as brand name for Quoin drug
(NASDAQ: QNRX) Delayed: 4.57 +0.20 (4.58%)
Previous Close $4.37    52 Week High
Open $4.40    52 Week Low
Day High $4.70    P/E N/A 
Day Low $4.33    EPS
Volume 30,227